The AACR-Johnson & Johnson Lung Cancer Initiative Clinical Oncology Research Training Fellowship is designed to provide an industry-academic clinical practicum with a unique opportunity for academic clinicians to train in drug development. Each fellowship provides $100,000 over one year for the fellow to work on site at the facility of AACR’s pharmaceutical industry partner, Johnson & Johnson.

2023 grantee

Biography

Dr. Lopetegui-Lia received her medical degree from the University Complutense of Madrid, Spain. After completing her internal medicine residency at the University of Connecticut, she was appointed as chief medical resident. She is currently a hematology/medical oncology fellow at the Cleveland Clinic where she has developed an interest in immuno-oncology and phase I clinical trials. In close collaboration with the Center for Immunotherapy and Precision Immuno-Oncology, she is studying immune cell subsets and their function as a novel means of understanding the effects of systemic therapy, and seeking to identify new strategies to effectively treat triple negative breast cancer. 

Acknowledgement of Support

“I am deeply honored to be awarded the 2023 AACR-Johnson & Johnson Lung Cancer Initiative Clinical Oncology Research Training Fellowship. This award will be instrumental in achieving my goal of being an independent researcher by honing my skills in designing innovative clinical trials and advancing my knowledge in drug development.”